Respiratory virosis and invasive bacterial superinfections: The case for influenza and meningococcal diseases;Viroses respiratoires et surinfections bactériennes invasives: Le cas de la grippe et des méningococcies

Archives de Pediatrie

Volumn 10, Issue 11, 2003, Pages 1013-1015

  Alonso, J M ^a   Taha, M K ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

Influenza; Meningococcal diseases; Pathophysiology Prevention; Superinfection

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; BACTERIAL SUPERINFECTION; CLINICAL FEATURE; DISEASE PREDISPOSITION; FEVER; GENERAL CONDITION IMPROVEMENT; IMMUNE DEFICIENCY; INFECTION PREVENTION; INFLAMMATION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A; MENINGOCOCCOSIS; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; RELAPSE; RESPIRATORY TRACT INFECTION; SYMPTOM; VIRUS INFECTION;

EID: 0242428511     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcped.2003.09.004     Document Type: Article

References (12)

1. Floret D. Co-infections virus-bactéries. Arch Pédiatr 1997;4: 1119-23.
2. Kim PE, Musher DM, Clezen WP, Rodriguez-Barradas MC, Nahm WK, Wright CE. Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin Infect Dis 1996;22:100-6.
3. Schwartzmann SW, Adler JL, Sullivan RJ, Marine WM. Bacterial pneumonia during the Hong Kong influenza epidemic of 1968-1969. Arch intern Med 1971;127:1037-41.
4. Cartwright KAV, Jones DM, Smith AJ, Stuart JM, Kaczmarski EB, Palmer SR. Influenza A virus and meningococcal disease. Lancet 1991;338:554-7.
5. Hubert B, Watier L, Garnerin P, Richardson S. Meningococcal disease and influenza-like syndrome: a new approach to an old question. J Infect Dis 1992;166:542-5.
6. Hartshorn KL. Etiology of bacterial superinfections complicating influenza virus infection 8. In: Brown LE, Hampson AW, Webster RG, editors. Options for the control of influenza III. Elsevier Science B.V; 1996. p. 499-550.
7. van Deuren M, Brandzaeg P, van Der Meer JWM. Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 2000;13:144-66.
8. Cartwright K. Meningococcal carriage and disease. In: Cartwright K, editor. Meningococcal Disease. Chichester, England: John Wiley & Sons; 1995. p. 115-46.
9. Alonso JM, Taha MK. Les infections à méningocoques en France: les données du Centre national de référence. MT Pédiatrie 2002;5: 191-5.
10. Hofmann P, Halbach U, Lehmann C, Sprenger H, Jacob M, Bussfeld D, et al. Activation of macrophages by influenza A virus infection: priming for cytokine production and death by apoptosis. In: Brown LE, Hampson AW, Webster RG, editors. Options for the control of influenza III. Elsevier Science B.V; 1996. p. 466-73.
11. Baumgarth N, Brown L, Jackson D, Kelso A. Novel features of the respiratory tract T-cell response to influenza virus infection: lung T cells increase expression of gamma interferon mRNA in vivo and maintain high levels of mRNA expression for interleukin-5 (IL-5) and IL-10. J Virol 1994;68:7575-81.
12. Alonso JM, Guiyoule A, Zarantonelli ML, Ramisse F, Pires R, Antignac A, et al. A model of meningococcal bacteremia after respiratory superinfection in influenza A virus-infected mice. FEMS Microbiol Let 2003;222:99-106.